Get the Stockscreener App
6.65
1.22%
0.08
After Hours:
6.66
0.010
+0.15%
Lifecore Biomedical Inc stock is traded at $6.65, with a volume of 208.54K.
It is up +1.22% in the last 24 hours and up +13.87% over the past month.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
See More
Previous Close:
$6.57
Open:
$6.59
24h Volume:
208.54K
Relative Volume:
1.00
Market Cap:
$243.44M
Revenue:
$128.45M
Net Income/Loss:
$6.54M
P/E Ratio:
133.00
EPS:
0.05
Net Cash Flow:
$-8.79M
1W Performance:
+3.42%
1M Performance:
+13.87%
6M Performance:
+18.33%
1Y Performance:
-7.51%
1-Day Range:
$6.52
$6.68
1-Week Range:
$6.24
$6.9326
52-Week Range:
$3.6793
$7.99
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Name
Lifecore Biomedical Inc
Sector
Phone
(952) 368-4300
Address
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
6.65 | 243.44M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
163.75 | 73.33B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.13 | 47.80B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.37 | 46.89B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.29 | 18.67B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.53 | 13.99B | 612.78M | -86.37M | -62.91M | -0.87 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-05-24 | Initiated | Craig Hallum | Buy |
| Aug-28-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-20-23 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Stock (LFCR) Latest News
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services for BIO 300 - Contract Pharma
Humanetics Selects Lifecore Biomedical To Deliver CDMO Services Supporting Development Of BIO 300 For The Prevention Of Acute Radiation Syndrome - Marketscreener.com
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome - The Manila Times
Humanetics Partners with Lifecore Biomedical for Development of BIO 300 Radioprotective Agent Funded by the Department of Defense - Nasdaq
Humanetics Selects Lifecore Biomedical to Deliver CDMO - GlobeNewswire
Lifecore Secures Major Defense Contract: Inside the $5.1M Radiation Protection Drug Program - StockTitan
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Steward Partners Investment Advisory LLC Has $202,000 Stock Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Learn to Evaluate (LFCR) using the Charts - Stock Traders Daily
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com
LFCR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - Markets Insider
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Bought by Rhumbline Advisers - Defense World
Is Lifecore Biomedical, Inc. (LFCR) the Best Micro Cap Stock to Buy Now? - Insider Monkey
Greenhaven Road Capital’s Updates on Lifecore Biomedical (LFCR) - Insider Monkey
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Reach Out - Markets Insider
LFCR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - Markets Insider
Lifecore Biomedical: We Are Not Playing To Make 5% Or 10% Here - Seeking Alpha
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences - The Manila Times
How Lifecore Biomedical Plans to Engage Investors at 3 Key Healthcare Conferences Next Month - StockTitan
When the Price of (LFCR) Talks, People Listen - Stock Traders Daily
Lifecore Biomedical (NASDAQ:LFCR) Trading 3.8% HigherHere's What Happened - MarketBeat
NASDAQ: LFCR Lawsuit NOTICE: Investors Who Lost Money With Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) Should Contact the Shareholders Foundation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - Markets Insider
Lifecore Biomedical (NASDAQ:LFCR) Stock Price Up 3.8% – Should You Buy? - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - Markets Insider
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
(LFCR) Technical Data - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation - Markets Insider
Sept. 27th Deadline Alert: Investors Who Lost More Than $100,000 With Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Should Contact the Shareholders Foundation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - Markets Insider
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - Markets Insider
Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference - The Manila Times
Exclusive: Lifecore Biomedical Leadership Team Takes Center Stage at Major BIO Investor Summit - StockTitan
(LFCR) Investment Analysis - Stock Traders Daily
Lifecore Biomedical’s Earnings Call: Growth Amid Challenges - TipRanks
This Lifecore Biomedical Insider Increased Their Holding In The Last Year - Yahoo Finance
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Purchased by Barclays PLC - Defense World
Here are Laughing Water Capital’s Updates on Lifecore Biomedical (LFCR) - Insider Monkey
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Sees Significant Increase in Short Interest - Defense World
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Short Interest Update - MarketBeat
Lifecore Biomedical Inc Stock (LFCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.19%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):